[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI945199A - HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit - Google Patents

HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit Download PDF

Info

Publication number
FI945199A
FI945199A FI945199A FI945199A FI945199A FI 945199 A FI945199 A FI 945199A FI 945199 A FI945199 A FI 945199A FI 945199 A FI945199 A FI 945199A FI 945199 A FI945199 A FI 945199A
Authority
FI
Finland
Prior art keywords
inhibitors
reverse transcriptase
hiv reverse
quinazolines
new
Prior art date
Application number
FI945199A
Other languages
English (en)
Swedish (sv)
Other versions
FI945199A0 (fi
Inventor
Terry A Lyle
Thomas J Tucker
Catherine M Wiscount
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI945199A0 publication Critical patent/FI945199A0/fi
Publication of FI945199A publication Critical patent/FI945199A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI945199A 1992-05-07 1994-11-04 HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit FI945199A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88011992A 1992-05-07 1992-05-07
US99116492A 1992-12-16 1992-12-16
PCT/US1993/003975 WO1993022292A1 (en) 1992-05-07 1993-04-28 New quinazolines as inhibitors of hiv reverse transcriptase

Publications (2)

Publication Number Publication Date
FI945199A0 FI945199A0 (fi) 1994-11-04
FI945199A true FI945199A (fi) 1994-11-04

Family

ID=27128564

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945199A FI945199A (fi) 1992-05-07 1994-11-04 HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit

Country Status (15)

Country Link
EP (2) EP0639184A1 (fi)
JP (1) JPH0813805B2 (fi)
KR (1) KR950701322A (fi)
CN (1) CN1085550A (fi)
AU (2) AU4220493A (fi)
BG (1) BG99149A (fi)
CA (1) CA2095194A1 (fi)
CZ (1) CZ272494A3 (fi)
FI (1) FI945199A (fi)
HR (1) HRP930857A2 (fi)
HU (1) HUT71401A (fi)
IL (1) IL105551A0 (fi)
MX (1) MX9302681A (fi)
SI (1) SI9300244A (fi)
WO (1) WO1993022292A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281297A (en) * 1993-08-27 1995-03-01 Merck & Co Inc Quinazoline compounds
US5434152A (en) * 1993-11-08 1995-07-18 Merck & Co., Inc. Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone
US6124302A (en) * 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
HRP980143A2 (en) * 1997-04-09 1999-02-28 Soo Sung Ko 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
EP1091939A1 (en) * 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
CA2370141A1 (en) 1999-05-26 2000-12-07 James D. Rodgers 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
EP1189882A1 (en) * 2000-04-25 2002-03-27 SAMSUNG ELECTRONICS Co. Ltd. Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
US7119111B2 (en) * 2002-05-29 2006-10-10 Amgen, Inc. 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
JP5470043B2 (ja) * 2007-10-05 2014-04-16 Msd株式会社 ベンゾオキサジノン誘導体
CN101544630B (zh) * 2009-05-13 2013-03-13 中国科学院广州生物医药与健康研究院 羟基化茚地那韦的制备方法
WO2017003724A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
WO2019023278A1 (en) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. MODULATORS OF SOMATOSTATIN AND USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL147140B (nl) * 1968-11-26 1975-09-15 Farmaceutici Italia Werkwijze voor het bereiden van geneesmiddelen met een remmende werking op het centrale zenuwstelsel.
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1993022292A1 (en) 1993-11-11
JPH0813805B2 (ja) 1996-02-14
JPH069578A (ja) 1994-01-18
HRP930857A2 (en) 1995-06-30
CN1085550A (zh) 1994-04-20
FI945199A0 (fi) 1994-11-04
IL105551A0 (en) 1993-08-18
CA2095194A1 (en) 1993-11-08
MX9302681A (es) 1994-05-31
AU3841393A (en) 1993-11-11
BG99149A (en) 1995-06-30
CZ272494A3 (en) 1995-10-18
SI9300244A (sl) 1993-12-31
KR950701322A (ko) 1995-03-23
HUT71401A (en) 1995-11-28
EP0569083A1 (en) 1993-11-10
AU4220493A (en) 1993-11-29
EP0639184A1 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
FI953954A (fi) HIV:n käänteistranskriptaasin inhibiittoreita
AU1046895A (en) New quinazolines as inhibitors of hiv reverse transcriptase
AU2436792A (en) Quinazoline derivatives as inhibitors of hiv reverse transcriptase
FI951059A (fi) HIV-aspartyyliproteaasin sulfonamidi-inhibiittoreita
DK0560268T3 (da) Substituerede pipecolinsyrederivater som HIV-proteasehæmmere
FR07C0034I2 (fr) Sulfamides d'hydroxyéthylamino utiles comme inhibiteurs de protéases rétrovirales
FI945199A (fi) HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit
AU2216292A (en) Inhibitors of hiv reverse transcriptase
NO954571D0 (no) Sialyl-LeX-analoger som inhibitorer av cellulær adhesjon
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
EP0462800A3 (en) Inhibitors of hiv reverse transcriptase
DK633189D0 (da) Anvendelse af peptidisostere som retrovirale proteasehaemmere
DK0641325T3 (da) Inhibitorer af retroviral protease
DK112387A (da) Rensning af alfa-1-antiprotease
NO934628D0 (no) Retrovirus-protease-inhibitorer
FI870971A (fi) Nya reaktionsprodukter och deras anvaendning som katalysatorer vid framstaellning av isocyanatbaserade plaster.
DK351788D0 (da) Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister
ATE125794T1 (de) Prodrogen von antiinflammatorischen 3-acyl-2- oxindol-1-carboxamiden.
NO864987D0 (no) Heteroaromatiske acetylener brukbare som antihypertensive midler.
AU7845191A (en) Inhibitors of HIV reverse transcriptase
NO944208D0 (no) Nye kinazoliner som inhibitorer av HIV-reverstranskriptase
FI80909B (fi) Anvaendning av fosfonsyraderivat som laederhjaelpmedel.
ZA933179B (en) New quinazolines as inhibitors of hiv reverse transcriptase.
GB9308781D0 (en) Inhibitors of hiv reverse transcriptase
ZA926130B (en) Quinazoline derivatives as inhibitors of hiv reverse transcriptase